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INTRODUCTION
Ideal endoscopic biopsy forceps should be able to obtain ad-
equate tissues for pathologic examination, operate without me-
chanical failure, easy to use, and not expose patients or practi-
tioners to cross-contamination or transmission of infection. 
Since endoscopic biopsy causes damage to mucosal barrier, 
there is high risk of transmitting infection. As with other med-
ical expendables, disposable biopsy forceps may preclude cross-
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contamination and transmission of infection.
1-5 Currently, re-
usable biopsy forceps are used most often since disposable bio-
psy forceps are considered more costly than the reusable ones 
in South Korea. Reusable biopsy forceps are more likely to har-
bor microorganisms due to the high possibility of the remnant 
organic adherent materials,
1,6,7 which might cause significant 
reprocessing cost for rigorous washing, disinfection, or steril-
ization. Given the reprocessing cost and the high price of reus-
able biopsy forceps, disposable forceps may be a good candi-
date for clinical use. Another barrier against using reusable 
forceps is the current medical insurance system, which covers 
only the cost of therapeutic disposable forceps, not of steriliza-
tion and reprocessing of reusable biopsy forceps. Recently, low-
priced disposable biopsy forceps are introduced in the market, 
calling for cost-effectiveness comparison with reusable biopsy 
forceps. This study was aimed to evaluate whether disposable 
biopsy forceps are more beneficial than reusable biopsy forceps, 
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in terms of performance and cost, in a tertiary hospital setting.
MATERIALS AND METHODS
This study was designed as a randomized comparative trial 
of disposable biopsy forceps versus reusable biopsy forceps. 
Subjects included patients undergoing upper gastrointestinal 
endoscopy at Seoul St. Mary’s Hospital between October 
2009 and July 2010. The target numbers of endoscopic biop-
sies were 200 patients. 5 reusable biopsy forceps (FB-21K-1; 
Olympus Co., Ltd., Tokyo, Japan) and 100 disposable biopsy 
forceps (FB-A-1-1600; Jiangsu Kangyou Medical Instrument 
Co., Ltd., Changzhou, China) were prepared, meaning 20 biop-
sies per 1 reusable forceps. The study was approved by the In-
stitutional Research Ethics Board of the Catholic University of 
Korea (KC09DISV0256) and was performed accordingly. Pa-
tients provided written informed consent before endoscopic 
examination. Patients with lesions requiring biopsy or rapid 
urease test [Campylobacter-like organism test] on endoscopic 
examination were randomly assigned to receive the biopsy us-
ing either disposable biopsy forceps or reusable biopsy forceps 
based on the table of random numbers. Additional 75 patients 
received biopsy to estimate durability of reusable biopsy forceps, 
resulting in 35 endoscopic biopsies per reusable biopsy forceps. 
An endoscopist performed all the endoscopic biopsies, and 3 
nurses assisted the endoscopy in turn. Reusable biopsy forceps 
were used once a day, and then reprocessed by washing with 
detergent, physical cleaning, rinsing, ultrasonic treatment, pack-
aging, and ethylene oxide gas sterilization for reuse. Disposable 
biopsy forceps were used in 1 patient and then discarded.
Primary variables included the general evaluation and costs 
of using biopsy forceps. For general evaluation of the biopsy for-
ceps, the assisting nurses scored the ease of forceps opening and 
closing as well as the ease of tissue separation from the forceps 
from 5 scales (excellent, 5; good, 4; adequate, 3; inadequate, 2; 
and poor, 1). The cost of biopsies included the purchase price, 
washing, sterilization, packaging, and labor costs of washing 
staffs. Secondary variable was the adequacy of samples, scored 
(≥2 mm, 5; 1.5 to 2.0 mm, 4; 1.0 to 1.5 mm, 3; 0.5 to 1.0 mm, 2; 
and <0.5 mm, 1) by measuring the diameters of the obtained 
tissue samples attached to a ruler-installed cork board.
SPSS version 13.0 (SPSS Inc., Chicago, IL, USA) was used for 
statistical analyses. Independent sample t-test was performed 
for analyses of continuous variables, and chi-square test for dis-
crete variables. p-values of less than 0.05 were considered sta-
tistically significant.
RESULTS
Among 100 patients in disposable biopsy forceps group, bi-
opsies were performed at 12 esophageal lesions, 159 gastric le-
sions, 7 duodenal lesions and 16 rapid urease tests, and mean 
2.51 (range, 1 to 12) tissues were obtained. Among 175 pa-
tients in reusable biopsy forceps group, biopsies were per-
formed at 20 esophageal lesions, 235 gastric lesions, 3 duode-
nal lesions and 39 rapid urease tests, and mean 2.51 (range, 1 
to 6) tissues were obtained (Table 1).
Disposable biopsy forceps were generally estimated as excel-
lent in 97.0%, good in 2.0% and adequate in 1.0%. Reusable 
biopsy forceps were generally estimated as excellent in 36.0%, 
good in 36.0%, adequate in 25.1% and inadequate in 2.9% 
(Table 2). The performance of reusable forceps declined with 
the number of uses. Five reusable biopsy forceps were firstly as-
sessed as adequate at 4, 10, 13, 18, and 24 times used (mean, 
13.8), respectively, and 3 reusable forceps were firstly assessed 
Table 1. Number and Site of Endoscopic Biopsies 
Variable
Disposable biopsy 
forceps (n=100)
Reusable biopsy 
forceps (n=175)
p-
value
No. of sample (range) 2.51 (1-12) 2.51 (1-6) NS
Location, mean±SD
Esophagus 0.12±0.33 0.11±0.34 NS
Stomach 1.59±1.20 1.34±0.95 0.08
Duodenum 0.07±0.29 0.02±0.13 0.09
CLO test 0.16±0.37 0.22±0.42 NS
NS, not significant; SD, standard deviation; CLO test, Campylo-
bacter-like organism test.
Table 2. Performance of Biopsy Forceps
Score 
Disposable 
biopsy forceps (n=100)
Reusable biopsy 
forceps (n=175)
p-
value
5    97 (97.0)    63 (36.0)
<0.001
4    2 (2.0)    63 (36.0)
3    1 (1.0)    44 (25.1)
2 0 (0)    5 (2.9)
1 0 (0) 0 (0)
Values are presented as number (%).
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Fig. 1. Performance of reusable biopsy forceps according to num-
ber of uses.
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as inadequate at 24, 26, and 32 times, respectively (Figs. 1, 2).
The reprocessing cost of reusable forceps for one biopsy ses-
sion was calculated as \8,021 (Table 3). The purchase price 
of reusable biopsy forceps was \353,000. The cost per use 
was calculated as \42,519, \25,270, \19,520, \16,645, and 
\14,921, if the forceps were used 10, 20, 30, 40, and 50 times 
(Fig. 3).
The mean adequacies of the samples were 4.98±0.09 and 
4.93±0.21 in disposable forceps group and reusable forceps 
group, respectively, without significant difference between the 
5 reusable forceps and disposable forceps (Fig. 4). The reusable 
biopsy forceps group did not show a change in adequacy of sam-
ple as the number of use increased.
DISCUSSION
This is the first study in South Korea to compare cost-effec-
tiveness of reusable biopsy forceps and disposable biopsy for-
ceps. The reprocessing cost of reusable biopsy forceps was 
\8,021 at Seoul St. Mary’s Hospital. When the numbers of up-
per gastrointestinal endoscopic biopsies performed in 2008 
are divided by the numbers of newly-purchased reusable biop-
sy forceps during the same period, the lifetime of reusable bi-
opsy forceps is estimated to be 50 times of use, in which case 
the cost of one biopsy, including the purchase price of the for-
ceps, mounts to as high as \14,921. The disposable forceps in-
vestigated in this study costs \13,200 with superior perfor-
mance, indicating that the disposable forceps are clinically more 
beneficial.
The performance of biopsy forceps in this study was estimat-
ed by assisting nurses based on the general evaluation and the 
size of the obtained tissues. Disposable biopsy forceps received 
generally excellent grade, without any trouble in obtaining max-
imum 12 tissues per biopsy. Reusable biopsy forceps, on the con-
trary, were graded adequate or inadequate, in the general esti-
mation, with the increasing number of use. The nurses pointed 
out that the reusable biopsy forceps did not open and close 
smoothly as the number of use increased.
Reusable biopsy forceps were used up to 35 times for dura-
bility evaluation and were not found as poor in the general eval-
uation, did not cause any functional disturbance, and the ade-
quacy of the obtained samples were good. It was apparent, 
1
2
3
4
5
M
e
a
n
 
s
c
o
r
e
Fig. 2. Mean score of performance of the reusable biopsy forceps 
according to number of uses.
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Table 3. Reusable Biopsy Forceps Processing Costs
Cost of supplies and processing (per biopsy forceps) Cost, won (\)
I. Washing in fresh detergents
1. Proteolytic enzyme (\19,980/L, 8 mL/L, 146 cc) 0140
2. Gloves (\75, 1 pair) 0150
3. Disposable gown (\75, one) 0077
4. Tap water (\1,285/ton, 13 L) 0017
5. Goggles (\32,000, 240 time) 0133
6. Disposable mask (\70, one) 0070
7. Disposable arm cover (\150, 1 pair) 0300
II. Mechanical cleaning
1. Brush (\12,100, 800 time) 0015
2. Gauze (\10, one) 0010
3. Neutral detergent (\1,692/L, 50 cc) 0085
III. Rinsing
1. Tap water (\1,285/ton, 30 L) 0039
2. Gloves (\75, 1 pair) 0150
IV. Ultrasonic treatment
1. Electric power (\100/kW, 30 min) 0025
2. Proteolytic enzyme (\19,980/L, 8 mL/L, 64 cc) 0043
3. Tap water (\1,285/ton, 8 L) 0010
V. Rinsing
1. Plastic gloves (\7.5, 1 pair) 0015
VI. Packaging
1. Sterilizer pouch (\62,700, 300 time) 0209
VII. Ethylene oxide sterilization
1. Cycle (\500,000, 80 forceps in one cycle) 6,250
VIII. Labor costs
1. Technician salary (\8,497/hr, 40 min, 20 forceps) 00283
Total cost 8,021
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Fig. 3. Cost per use of reusable biopsy forceps with the number of 
uses.
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however, that the performance of reusable biopsy forceps de-
creased as the number of use increased, which is comparable 
to previous studies reporting reduced performance of reusable 
biopsy forceps as the number of use increased.
8 Some studies 
even reported malfunction.
9 
The reprocessing cost of reusable biopsy forceps were esti-
mated at \8,021 at Seoul St. Mary’s Hospital. The previous 
studies using similar method for cost analysis reported higher 
($11.77 and $16.56) reprocessing cost per use.
8,9 Another stud-
ies analyzing annual total cost reported $3.25 and $4.39 for re-
processing cost per use.
10,11 Reusable biopsy forceps require a 
significant cost for reprocessing, which might be influenced by 
multiple factors such as the number of biopsy, expendables, 
method of sterilization, labor cost and method of calculation. 
In this study, the ethylene oxide gas sterilization accounted the 
largest portion of the reprocessing cost, which is also the case 
for a previous study.
9 In addition, the work load of biopsy for-
ceps reprocessing for the washing staff accounted for about 15% 
of the total work load, suggesting that disposable biopsy for-
ceps might lower some of the labor cost. 
Various pathogens, such as Salmonella species, Pseudomo-
nas aeruginosa, Helicobacter pylori, Strongyloides stercoralis, 
hepatitis B virus and hepatitis C virus, may be transmitted th-
rough endoscopy.
1,5,12-15 Since endoscopic biopsy causes dam-
age to mucosal barrier, there is high risk of transmitting infec-
tion. It is important, therefore, to remove all the organic adhe-
rent materials on biopsy forceps for adequate reprocessing.
6,7 
These organic adherent materials are likely to remain on biop-
sy forceps, due to mechanical properties, and survive even af-
ter reprocessing.
1 There were reports of remnant tissue materi-
als and scratches found by scanning electron microscope on the 
surface of biopsy forceps reused for more than 20 times, and iso-
lation of Escherichia coli from sterilized biopsy forceps.
16 It is 
recommended, by the guidelines of endoscopy disinfection to 
sterilize or disinfect endoscope components, and if possible 
use steam sterilization. Given that endoscopy is performed in 
primary healthcare institutions where sterilization is more dif-
ficult, use of disposable forceps should be approved consider-
ing the survivability of microorganisms on reusable forceps. It 
seems reasonable to use disposable biopsy forceps or at least 
sterilize, rather than disinfect, reusable forceps, for patients with 
AIDS, hepatitis B or hepatitis C.
In conclusion, disposable biopsy forceps, with its superior 
performance and less cost than reusable biopsy forceps, need 
to be considered for clinical use. It is reasonable, in terms of cost-
effectiveness, to use disposable forceps for high risk patients of 
infection through biopsy forceps.
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